These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1491243)

  • 21. Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia.
    Oertel WH
    Arzneimittelforschung; 1995 Mar; 45(3A):386-9. PubMed ID: 7763330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The validity of the GaitRite and the Functional Ambulation Performance scoring system in the analysis of Parkinson gait.
    Nelson AJ; Zwick D; Brody S; Doran C; Pulver L; Rooz G; Sadownick M; Nelson R; Rothman J
    NeuroRehabilitation; 2002; 17(3):255-62. PubMed ID: 12237507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound in the (premotor) diagnosis of Parkinson's disease.
    Berg D
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S429-33. PubMed ID: 18267277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.
    Merello M; Nouzeilles MI; Arce GP; Leiguarda R
    Mov Disord; 2002 Jul; 17(4):795-8. PubMed ID: 12210878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early diagnosis of Parkinson's disease and initiation of treatment.
    Weiner WJ
    Rev Neurol Dis; 2008; 5(2):46-53; quiz 54-5. PubMed ID: 18660736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Methods for the early diagnosis of Parkinson's disease].
    Becker G
    Nervenarzt; 2003 Mar; 74 Suppl 1():S7-11. PubMed ID: 12624678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
    Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
    Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
    Rouco I; Gómez JC; Lezcano E; Aniel-Quiroga MA; Velasco F; Barcena J; Pérez Bas M; Hurtado P; Cruz Lachén M; Zarranz JJ
    Neurologia; 2006 Apr; 21(3):119-23. PubMed ID: 16575624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET and SPECT functional imaging in Parkinson's disease.
    Antonini A; DeNotaris R
    Sleep Med; 2004 Mar; 5(2):201-6. PubMed ID: 15033144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional imaging in Parkinson disease.
    Nandhagopal R; McKeown MJ; Stoessl AJ
    Neurology; 2008 Apr; 70(16 Pt 2):1478-88. PubMed ID: 18413571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of acute tryptophan depletion on cognition, memory and motor performance in Parkinson's disease.
    Scholtissen B; Verhey FR; Adam JJ; Prickaerts J; Leentjens AF
    J Neurol Sci; 2006 Oct; 248(1-2):259-65. PubMed ID: 16756999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder.
    Postuma RB; Lang AE; Massicotte-Marquez J; Montplaisir J
    Neurology; 2006 Mar; 66(6):845-51. PubMed ID: 16567700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Presymptomatic detection of Parkinson's disease].
    Berendse HW; Booij J; Stoffers D; Ponsen MM; Hijman R; Wolters ECh
    Tijdschr Gerontol Geriatr; 2002 Apr; 33(2):70-7. PubMed ID: 12012945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single photon emission computer tomography of dopamine transporters in monkeys and humans with 99mTc-TRODAT-1.
    Hu P; Chen L; Zhang HQ; Li JR; Liang H
    Chin Med J (Engl); 2004 Jul; 117(7):1056-9. PubMed ID: 15265382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cerebrospinal fluid biomarkers for the early diagnosis of Parkinson's disease].
    da Costa AG; Gago MF; Garrett C
    Acta Med Port; 2011 Dec; 24 Suppl 4():761-8. PubMed ID: 22863482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Motor signs in the prodromal phase of Parkinson's disease.
    Maetzler W; Hausdorff JM
    Mov Disord; 2012 Apr; 27(5):627-33. PubMed ID: 22437964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prerequisites to launch neuroprotective trials in Parkinson's disease: an industry perspective.
    Streffer JR; Grachev ID; Fitzer-Attas C; Gomez-Mancilla B; Boroojerdi B; Bronzova J; Ostrowitzki S; Victor SJ; Fontoura P; Alexander R
    Mov Disord; 2012 Apr; 27(5):651-5. PubMed ID: 22508283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis of Parkinson's disease].
    Arias-Rodríguez M; Morís-De la Tassa G
    Rev Neurol; 2009 Jan; 48 Suppl 1():S21-5. PubMed ID: 19222011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.